-

SHAREHOLDER ALERT: Robbins LLP Announces That MoneyGram International, Inc. (MGI) is Being Sued for Misleading Shareholders

SAN DIEGO & DALLAS--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of MoneyGram International, Inc. (NASDAQ: MGI) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between June 17 2019 and February 22, 2021.

If you suffered a loss due to MoneyGram International Inc.'s misconduct, click here.

MoneyGram International, Inc. (MGI) Misled Investors About

According to the complaint, on June 17, 2019, MoneyGram announced it was entering into a strategic partnership with Ripple Labs, Inc. Ripple is a blockchain technology company and the developer of cryptocurrency XRP. As part of the partnership, Ripple agreed to invest up to $50 million in MoneyGram stock. On this news, the price of MoneyGram stock increased over 150%. Throughout the relevant period, MoneyGram touted the partnership, stating that it will reduce our working capital needs and generate additional earnings and cash flows." The Company also made statements regarding the strong contribution that market development fees received from Ripple made to MoneyGram's financial results.

On December 22, 2020, the Securities and Exchange Commission ("SEC") filed a lawsuit against Ripple, alleging that Ripple's cryptocurrency XRP is an unregistered security in violation of the securities laws. With regard to MoneyGram's involvement, the SEC complaint explains that the major non-investment use of the XRP cryptocurrency is transferring money on Ripple's ODL platform and that in order to convince anyone to use ODL to transfer money, Ripple had to make a $50 million equity investment and pay sufficient financial compensation to an entity referred to as the "Money Transmitter," i.e., MoneyGram. The SEC complaint further explains how MoneyGram took park in the sale of unregistered XRP securities on the open market.

On February 22, 2021, MoneyGram filed its annual report on Form 10-K for the year ended December 31, 2020, stating: "MoneyGram ceased transacting with Ripple under the commercial agreement in early December 2020 and has not resumed trading. It is possible that MoneyGram will not resume transacting with Ripple … and will be unable to receive the related market development fees in 2021 and beyond." On this news, MoneyGram stock fell 33.2%, from a closing price of $10.87 on February 19, 2021, to $7.26 on February 23, 2021.

If you purchased shares of MoneyGram International Inc. (MGI) between June 17, 2019 and February 22, 2021, you have until April 30, 2021, to ask the court to appoint you lead plaintiff for the class.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against MoneyGram International, Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

POET Technologies Inc. Class Action Reminder - Robbins LLP Encourages POET Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57 A.M. ET on April 27, 2026. POET Technologies describes itself as a "design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photoni...

Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug CandidateOn May 5, 2026, a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related i...
Back to Newsroom